
KromaTiD awarded Direct to Phase II SBIR grant by the National Human Genome Research Institute
LONGMONT -- KromaTiD, Inc. today announced it has been awarded a Direct to Phase II SBIR grant by the National Human Genome Research Institute. The award supports development of a structural... Read More
Monday August 24, 2020 0 comments